Clinigence Holdings (NUTX) Price & Analysis

Compare

351 Followers

NUTX Stock Chart & Stats

$111.00

-$1.17(-3.51%)

At close: Jan 08 4:00 PM EST

$111.00

-$1.17(-3.51%)

Day’s Range― - ―

52-Week Range$25.86 - $184.28

Previous CloseN/A

Volume3.28K

Average Volume (3M)111.96K

Market Cap

$729.50M

Enterprise ValueN/A

Total Cash (Recent Filing)$84.73M

Total Debt (Recent Filing)$341.36M

Price to Earnings (P/E)10.2

Beta2.10

Next Earnings

Mar 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding5,555,116

10 Day Avg. Volume96,264

30 Day Avg. Volume111,956

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)1.10

Price to Sales (P/S)0.34

P/FCF Ratio7.75

Enterprise Value/Market Cap0.00

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price Target

$252.50

Price Target Upside127.48% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Expansion PlansNutex Health Inc. is on track to open 2–3 new micro-hospitals during 2025, indicating growth and expansion potential.

Financial PositionNutex has sufficient capital to maintain current operations and advance expansion plans, with cash of $96.4M and debt of $35.5M as of June 30, 2025.

Revenue GrowthPreliminary 2Q25 revenue exceeded expectations, reflecting continued success in leveraging the No Surprises Act arbitration process, with favorable outcomes in roughly 80% of cases.

Bears Say

Accounting IssuesNutex filed an NT 10-Q notification of inability to timely file its 10-Q due to the incorrect accounting classification of certain non-cash obligations, leading to the need for restatements.

Arbitration ChallengesPotential headwinds to NUTX's stock price include arbitration dynamics, which could impact future financial performance.

Legal ChallengesPotential headwinds to NUTX's stock price include accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD.

Clinigence Holdings News

NUTX Lawsuit Alert! Class Action Lawsuit Against Nutex Health

A class action lawsuit was filed against Nutex Health ($NUTX) on August 22, 2025. The plaintiffs (shareholders) alleged that they bought...

17d ago

NUTX

Nutex Health reports Q3 estimated patient volume $46.29M, up 11.1%

Reports Q3 estimated cash collections $235M, up 258.8%. The third quarter saw patient volumes rise 11.1% compared to...

19d ago

NUTX

Clinigence Holdings Granted Extension for Nasdaq Compliance

An announcement from Clinigence Holdings ( ($NUTX) ) is now available. On August 20, 2025, Clinigence Holdings received...

19d ago

NUTX

Nutex Health Appoints New Chief Operating Officer

Clinigence Holdings ( ($NUTX) ) has issued an update. On September 22, 2025, Nutex Health Inc. announced the...

2M ago

NUTX

Nutex Health appoints Wesley Bamburg as COO

Nutex Health (NUTX) announced the appointment of Wesley Bamburg as the company’s COO, effective October 13. Bamburg has...

2M ago

HCA

NUTX

Clinigence Holdings Faces Derivative Action Lawsuit

Clinigence Holdings ( ($NUTX) ) has provided an update. On September 8, 2025, a derivative action was filed...

2M ago

NUTX

Nutex Health Appoints New Lead Independent Director

An update from Clinigence Holdings ( ($NUTX) ) is now available. On September 2, 2025, Nutex Health, Inc....

2M ago

NUTX

Nutex Health Faces Class Action Over Fraud Allegations

Nutex Health Inc. finds itself embroiled in a legal storm as a class action lawsuit accuses the company...

2M ago

NUTX

Clinigence Holdings Inc. Earnings Call: Growth Amid Challenges

Clinigence Holdings Inc (($NUTX)) has held its Q2 earnings call. Read on for the main highlights of the...

2M ago

NUTX

Nutex Health price target lowered to $205 from $225 at Maxim

Maxim lowered the firm’s price target on Nutex Health (NUTX) to $205 from $225 and keeps a Buy...

2M ago

NUTX

Nutex Health Faces Securities Class Action Lawsuit

Clinigence Holdings ( ($NUTX) ) just unveiled an update. On August 22, 2025, a securities class action complaint...

2M ago

NUTX

Clinigence Holdings Faces Nasdaq Delisting Notice

The latest announcement is out from Clinigence Holdings ( ($NUTX) ). On August 20, 2025, Nutex Health Inc....

3M ago

NUTX

Nutex Health Reports Strong Revenue Growth Amid Filing Delay

Clinigence Holdings Inc ( ($NUTX) ) has released its Q2 earnings. Here is a breakdown of the information...

3M ago

NUTX

Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness

In the opening hour of the evening session, U.S. equity futures are mixed: S&P 500 is flat, Nasdaq...

3M ago

NUE

UNH

NUTX FAQ

What was Clinigence Holdings Inc’s price range in the past 12 months?

Clinigence Holdings Inc lowest stock price was $25.86 and its highest was $184.28 in the past 12 months.

What is Clinigence Holdings Inc’s market cap?

Clinigence Holdings Inc’s market cap is $729.50M.

When is Clinigence Holdings Inc’s upcoming earnings report date?

Clinigence Holdings Inc’s upcoming earnings report date is Mar 26, 2026 which is in 138 days.

How were Clinigence Holdings Inc’s earnings last quarter?

Currently, no data Available

Is Clinigence Holdings Inc overvalued?

According to Wall Street analysts Clinigence Holdings Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Clinigence Holdings Inc pay dividends?

Clinigence Holdings Inc does not currently pay dividends.

What is Clinigence Holdings Inc’s EPS estimate?

Clinigence Holdings Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Clinigence Holdings Inc have?

Clinigence Holdings Inc has 5,555,116 shares outstanding.

What happened to Clinigence Holdings Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Clinigence Holdings Inc?

Currently, no hedge funds are holding shares in NUTX

Clinigence Holdings Stock Smart Score

Outperform

Company Description

Clinigence Holdings Inc

Clinigence Holdings (NUTX) is a healthcare technology company that specializes in providing data analytics and population health management solutions. The company operates in the healthcare sector, focusing on delivering innovative software and services that enhance the efficiency and effectiveness of healthcare providers. Clinigence's core offerings include advanced analytics platforms, telehealth solutions, and integrated care management tools, aimed at improving patient outcomes while reducing costs for healthcare organizations.

Clinigence Holdings (NUTX) Earnings & Revenues

Historic Earnings Reports

NUTX Stock 12 Month Forecast

Average Price Target

$252.50

▲(127.48% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","301":"$301","79.75":"$79.8","153.5":"$153.5","227.25":"$227.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$300.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":252.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$252.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$205.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,79.75,153.5,227.25,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,104.4,119.44615384615385,134.4923076923077,149.53846153846155,164.5846153846154,179.63076923076923,194.6769230769231,209.72307692307692,224.76923076923077,239.81538461538463,254.86153846153846,269.9076923076923,284.95384615384614,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,104.4,115.7923076923077,127.1846153846154,138.5769230769231,149.96923076923076,161.3615384615385,172.75384615384615,184.14615384615385,195.53846153846155,206.93076923076924,218.32307692307694,229.7153846153846,241.1076923076923,{"y":252.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,104.4,112.13846153846154,119.87692307692308,127.61538461538461,135.35384615384615,143.09230769230768,150.83076923076925,158.56923076923078,166.30769230769232,174.04615384615386,181.7846153846154,189.52307692307693,197.26153846153846,{"y":205,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.77,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.39,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.58,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.69,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.63,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":117.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.8,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.92,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >